المؤلفون: Gourdy, Pierre, Darmon, Patrice, Dievart, François, Halimi, Jean-Michel, Guerci, Bruno

المساهمون: Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE)

المصدر: ISSN: 1475-2840 ; Cardiovascular Diabetology ; https://amu.hal.science/hal-04395593Test ; Cardiovascular Diabetology, 2023, 22 (1), pp.79. ⟨10.1186/s12933-023-01798-4⟩.

مصطلحات موضوعية: Glucagon-like peptide-1 receptor agonists, Sodium-glucose cotransporter-2 inhibitors, Type 2 diabetes mellitus, Combination therapy, Cardiovascular protection, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37005640; hal-04395593; https://amu.hal.science/hal-04395593Test; https://amu.hal.science/hal-04395593/documentTest; https://amu.hal.science/hal-04395593/file/s12933-023-01798-4.pdfTest; PUBMED: 37005640; WOS: 000961475800002

الإتاحة: https://doi.org/10.1186/s12933-023-01798-4Test
https://amu.hal.science/hal-04395593Test
https://amu.hal.science/hal-04395593/documentTest
https://amu.hal.science/hal-04395593/file/s12933-023-01798-4.pdfTest

المؤلفون: Vergès, Bruno, Aboyans, Victor, Angoulvant, Denis, Boutouyrie, Pierre, Cariou, Bertrand, Hyafil, Fabien, Mohammedi, Kamel, Amarenco, Pierre

المساهمون: Lipides - Nutrition - Cancer Dijon - U1231 (LNC), Université de Bourgogne (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Agro Dijon, Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro)-Institut national d'enseignement supérieur pour l'agriculture, l'alimentation et l'environnement (Institut Agro), Epidémiologie des Maladies Chroniques en zone tropicale (EpiMaCT), CHU Limoges-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Institut National de la Santé et de la Recherche Médicale (INSERM)-OmégaHealth (ΩHealth), Université de Limoges (UNILIM)-Université de Limoges (UNILIM), Transplantation, Immunologie, Inflammation Tours (T2i), Université de Tours (UT), Paris-Centre de Recherche Cardiovasculaire (PARCC (UMR_S 970/ U970)), Hôpital Européen Georges Pompidou APHP (HEGP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), ITX-lab unité de recherche de l'institut du thorax UMR1087 UMR6291 (ITX-lab), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Nantes Université - UFR de Médecine et des Techniques Médicales (Nantes Univ - UFR MEDECINE), Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ)-Nantes Université - pôle Santé, Nantes Université (Nantes Univ)-Nantes Université (Nantes Univ), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpitaux Universitaires Paris Ouest - Hôpitaux Universitaires Île de France Ouest (HUPO), Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases, Université de Bordeaux (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), AP-HP - Hôpital Bichat - Claude Bernard Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)

المصدر: ISSN: 1475-2840 ; Cardiovascular Diabetology ; https://hal.science/hal-04013171Test ; Cardiovascular Diabetology, 2022, 21 (1), pp.242. ⟨10.1186/s12933-022-01686-3⟩.

مصطلحات موضوعية: Animals, Humans, Glucagon-Like Peptide-1 Receptor, Hypoglycemic Agents, Diabetes Mellitus, Type 2, Stroke, Hyperglycemia, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, [SCCO.NEUR]Cognitive science/Neuroscience, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36380358; hal-04013171; https://hal.science/hal-04013171Test; https://hal.science/hal-04013171/documentTest; https://hal.science/hal-04013171/file/BMC_Cardiovascular%20Diabetology%20_2022_Verg%C3%A8s.pdfTest; PUBMED: 36380358; PUBMEDCENTRAL: PMC9667639

الإتاحة: https://doi.org/10.1186/s12933-022-01686-3Test
https://hal.science/hal-04013171Test
https://hal.science/hal-04013171/documentTest
https://hal.science/hal-04013171/file/BMC_Cardiovascular%20Diabetology%20_2022_Verg%C3%A8s.pdfTest

المؤلفون: Faillie, Jean-Luc, Yin, Hui, Yu, Oriana, Herrero, Astrid, Altwegg, Romain, Renoux, Christel, Azoulay, Laurent

المساهمون: Institut Desbrest de santé publique (IDESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), CHU Montpellier, Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Lady Davis Institute for Medical Research Montréal, McGill University = Université McGill Montréal, Canada -Jewish General Hospital, Jewish General Hospital, McGill University = Université McGill Montréal, Canada

المصدر: ISSN: 0009-9236.

مصطلحات موضوعية: MESH: Aged, MESH: Cohort Studies, MESH: Intestinal Obstruction, MESH: Male, MESH: Middle Aged, MESH: Odds Ratio, MESH: Propensity Score, MESH: Proportional Hazards Models, MESH: Sodium-Glucose Transporter 2 Inhibitors, MESH: United Kingdom, MESH: Diabetes Mellitus, Type 2, MESH: Dipeptidyl-Peptidase IV Inhibitors, MESH: Female, MESH: Glucagon-Like Peptide-1 Receptor, MESH: Humans, MESH: Hypoglycemic Agents, MESH: Incidence, MESH: Incretins, [SDV.MHEP]Life Sciences [q-bio]/Human health and pathology, [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34587280; hal-03853682; https://hal.umontpellier.fr/hal-03853682Test; https://hal.umontpellier.fr/hal-03853682/documentTest; https://hal.umontpellier.fr/hal-03853682/file/Faillie_al_CPT_2022.pdfTest; PUBMED: 34587280

الإتاحة: https://doi.org/10.1002/cpt.2430Test
https://hal.umontpellier.fr/hal-03853682Test
https://hal.umontpellier.fr/hal-03853682/documentTest
https://hal.umontpellier.fr/hal-03853682/file/Faillie_al_CPT_2022.pdfTest

المؤلفون: Lucey, Maria, Ashik, Tanyel, Marzook, Amaara, Wang, Yifan, Goulding, Joëlle, Oishi, Atsuro, Broichhagen, Johannes, Hodson, David, J, Minnion, James, Elani, Yuval, Jockers, Ralf, Briddon, Stephen, J, Bloom, Stephen, R, Tomas, Alejandra, Jones, Ben

المساهمون: Imperial College London, University of Birmingham Birmingham, Institut Cochin (IC UM3 (UMR 8104 / U1016)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Kyorin University School of Medicine Tokyo, Japan, Kyorin University Tokyo, Japan, Leibniz Forschungsinstitut für Molekulare Pharmakolgie = Leibniz Institute for Molecular Pharmacology Berlin, Allemagne (FMP), Leibniz Association, Department of Chemical Engineering London, ANR-15-CE14-0025,GlioShuttles4Metabolism,Les tanycytes transportent la leptine dans le cerveau: identification des mécanismes et rôle dans la physiopathologie de l'obésité et du diabète(2015), ANR-19-CE16-0025,mitoGPCR,Les récepteurs couplés aux protéines G mitochondriaux en neuroprotection(2019)

المصدر: ISSN: 0026-895X ; Molecular Pharmacology ; https://hal.science/hal-03535615Test ; Molecular Pharmacology, 2021, 100 (4), pp.319-334. ⟨10.1124/molpharm.121.000270⟩.

مصطلحات موضوعية: Incretins, Insulin Secretion, Inbred C57BL, Protein Transport, Signal Transduction, HEK293 Cells, Exenatide, Glucagon-Like Peptide-1 Receptor, Acylation, [SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34315812; hal-03535615; https://hal.science/hal-03535615Test; https://hal.science/hal-03535615/documentTest; https://hal.science/hal-03535615/file/319.full.pdfTest; PUBMED: 34315812

الإتاحة: https://doi.org/10.1124/molpharm.121.000270Test
https://hal.science/hal-03535615Test
https://hal.science/hal-03535615/documentTest
https://hal.science/hal-03535615/file/319.full.pdfTest

المؤلفون: Mosenzon, Ofri, Alguwaihes, Abdullah, Leon, Jose Luis Arenas, Bayram, Fahri, Darmon, Patrice, Davis, Timothy, Dieuzeide, Guillermo, Eriksen, Kirsten, Hong, Tianpei, Kaltoft, Margit, Lengyel, Csaba, Rhee, Nicolai, Russo, Giuseppina, Shirabe, Shinichiro, Urbancova, Katerina, Vencio, Sergio

المساهمون: The Hebrew University of Jerusalem (HUJ), King Saud University Riyadh (KSU), Erciyes University, Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), The University of Western Australia (UWA), Novo Nordisk Inc, NOVO NORDISK PARK, Peking University Beijing, University of Szeged Szeged, Novo nordisk pharma, University of Messina

المصدر: ISSN: 1475-2840 ; Cardiovascular Diabetology ; https://amu.hal.science/hal-03653398Test ; Cardiovascular Diabetology, 2021, 20 (1), pp.154. ⟨10.1186/s12933-021-01344-0⟩.

مصطلحات موضوعية: Cardiovascular disease, Glucagon-like peptide-1 receptor agonists, Non-interventional study, Prevalence, Sodium-glucose co-transporter-2 inhibitors, Type 2 diabetes, Atherosclerotic cardiovascular disease, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34315481; hal-03653398; https://amu.hal.science/hal-03653398Test; https://amu.hal.science/hal-03653398/documentTest; https://amu.hal.science/hal-03653398/file/12933_2021_Article_1344.pdfTest; PUBMED: 34315481; PUBMEDCENTRAL: PMC8317423; WOS: 000678653700004

الإتاحة: https://doi.org/10.1186/s12933-021-01344-0Test
https://amu.hal.science/hal-03653398Test
https://amu.hal.science/hal-03653398/documentTest
https://amu.hal.science/hal-03653398/file/12933_2021_Article_1344.pdfTest

المؤلفون: Vincent W.S. Wong, Shira Zelber‐Sagi, Kenneth Cusi, Patrizia Carrieri, Eugene Wright, Javier Crespo, Jeffrey V. Lazarus

المساهمون: The Chinese University of Hong Kong [Hong Kong], University of Haifa [Haifa], University of Florida [Gainesville] (UF), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut des sciences de la santé publique [Marseille] (ISSPAM), Duke University [Durham], Hospital Universitario Marqués de Valdecilla [Santander], Marqués de Valdecilla Research Institute - Instituto de Investigación Marqués de Valdecilla [Santander] (IDIVAL), Instituto de Salud Global - Institute For Global Health [Barcelona] (ISGlobal), University of Barcelona

المصدر: Liver International
Liver International, 2022, 42 (11), pp.2377-2389. ⟨10.1111/liv.15404⟩

مصطلحات موضوعية: Liver Cirrhosis, general practice, MESH: Humans, Primary Health Care, Hepatology, MESH: Non-alcoholic Fatty Liver Disease, cirrhosis, [SDV]Life Sciences [q-bio], non-alcoholic fatty liver disease, MESH: Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor, MESH: Primary Health Care, non-alcoholic steatohepatitis, Humans, MESH: Liver Cirrhosis, liver fibrosis

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58808da3ed3152caa1fb70ff81312d15Test
https://www.hal.inserm.fr/inserm-04051853/documentTest

المؤلفون: Ferreira, João Pedro, Sharma, Abhinav, Butler, Javed, Packer, Milton, Zannad, Faiez, Vasques-Nóvoa, Francisco, Leite-Moreira, Adelino, Neves, João Sérgio

المساهمون: Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin Nancy (CIC-P), Centre d'investigation clinique Nancy (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists Vandoeuvre-les-Nancy (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu Nancy, French-Clinical Research Infrastructure Network - F-CRIN Paris (Cardiovascular & Renal Clinical Trialists - CRCT ), Heart Failure Clinic, Centro Hospitalar de Vila Nova de Gaia/Espinho, Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto = University of Porto, McGill University = Université McGill Montréal, Canada, Baylor Scott & White Research Institute (BSWRI), Baylor College of Medecine, Imperial College London, Hospital de São João Porto, This work was financed by national funds through FCT (Fundação para a Ciência e Tecnologia), I.P., within the scope of the Cardiovascular R&D Center (UIDB/00051/2020 and UIDP/00051/2020) and RISE (LA/P/0053/2020).

المصدر: ISSN: 0021-972X.

مصطلحات موضوعية: Glucagon-like peptide-1 receptor agonists, Heart failure, Risk modification, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37409733; hal-04157665; https://hal.univ-lorraine.fr/hal-04157665Test; https://hal.univ-lorraine.fr/hal-04157665/documentTest; https://hal.univ-lorraine.fr/hal-04157665/file/GLP1RA_HF_risk.pdfTest; PUBMED: 37409733

الإتاحة: https://doi.org/10.1210/clinem/dgad398Test
https://hal.univ-lorraine.fr/hal-04157665Test
https://hal.univ-lorraine.fr/hal-04157665/documentTest
https://hal.univ-lorraine.fr/hal-04157665/file/GLP1RA_HF_risk.pdfTest

المؤلفون: João Pedro Ferreira, João Sérgio Neves

المساهمون: Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT ), Cardiovascular R&D Centre-UnIC@RISE, Faculdade de Medicina da Universidade do Porto (FMUP), Universidade do Porto = University of Porto, Hospital de São João [Porto], BOZEC, Erwan

المصدر: European Journal of Heart Failure
European Journal of Heart Failure, 2022, 24 (10), pp.1813-1815. ⟨10.1002/ejhf.2693⟩

مصطلحات موضوعية: Heart Failure, Diabetes Mellitus, Type 2, [SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system, Glucagon-Like Peptide 1, Cardiovascular Diseases, Humans, Hypoglycemic Agents, Cardiology and Cardiovascular Medicine, Glucagon-Like Peptide-1 Receptor, [SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53614d9b1a490359ac85fdf2fc22ca3bTest
https://hal.univ-lorraine.fr/hal-03796731/documentTest

المؤلفون: Bezin, Julien, Gouverneur, Amandine, Penichon, Marine, Mathieu, Clement, Garrel, Renaud, Hillaire-Buys, Dominique, Pariente, Antoine, Faillie, Jean-Luc

المساهمون: Bordeaux population health (BPH), Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Bordeaux, CHU Montpellier, Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Institut Desbrest de santé publique (IDESP), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM)

المصدر: ISSN: 0149-5992.

مصطلحات موضوعية: MESH: Diabetes Mellitus, Type 2 / diagnosis, MESH: Glucagon-Like Peptide 1 / adverse effects, MESH: Glucagon-Like Peptide-1 Receptor / agonists, MESH: Humans, MESH: Hypoglycemic Agents / adverse effects, MESH: Thyroid Neoplasms / chemically induced, MESH: Thyroid Neoplasms / epidemiology, [SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie, [SDV.MHEP.EM]Life Sciences [q-bio]/Human health and pathology/Endocrinology and metabolism

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/36356111; hal-03900050; https://hal.science/hal-03900050Test; PUBMED: 36356111

الإتاحة: https://doi.org/10.2337/dc22-1148Test
https://hal.science/hal-03900050Test

المؤلفون: Wong, Vincent, W S, Zelber‐sagi, Shira, Cusi, Kenneth, Carrieri, Patrizia, Wright, Eugene, Crespo, Javier, Lazarus, Jeffrey, V

المساهمون: The Chinese University of Hong Kong Hong Kong (CUHK), University of Haifa Haifa, University of Florida Gainesville (UF), Sciences Economiques et Sociales de la Santé & Traitement de l'Information Médicale (SESSTIM - U1252 INSERM - Aix Marseille Univ - UMR 259 IRD), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut des sciences de la santé publique Marseille (ISSPAM), Duke University Durham, Hospital Universitario Marqués de Valdecilla Santander, Marqués de Valdecilla Research Institute - Instituto de Investigación Marqués de Valdecilla Santander (IDIVAL), Instituto de Salud Global - Institute For Global Health Barcelona (ISGlobal), University of Barcelona

المصدر: ISSN: 1478-3223.

مصطلحات موضوعية: cirrhosis, general practice, liver fibrosis, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, MESH: Glucagon-Like Peptide-1 Receptor, MESH: Humans, MESH: Liver Cirrhosis, MESH: Non-alcoholic Fatty Liver Disease, MESH: Primary Health Care, [SDV]Life Sciences [q-bio]

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/35986897; inserm-04051853; https://inserm.hal.science/inserm-04051853Test; https://inserm.hal.science/inserm-04051853/documentTest; https://inserm.hal.science/inserm-04051853/file/Liver%20International%20-%202022%20-%20Wong.pdfTest; PUBMED: 35986897

الإتاحة: https://doi.org/10.1111/liv.15404Test
https://inserm.hal.science/inserm-04051853Test
https://inserm.hal.science/inserm-04051853/documentTest
https://inserm.hal.science/inserm-04051853/file/Liver%20International%20-%202022%20-%20Wong.pdfTest